Steven Cohen Rapt Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 707,300 shares of RAPT stock, worth $2.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
707,300
Previous 707,300
-0.0%
Holding current value
$2.19 Million
Previous $2.16 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RAPT
# of Institutions
124Shares Held
29.1MCall Options Held
903KPut Options Held
592K-
Vanguard Group Inc Valley Forge, PA3.11MShares$9.64 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$8.31 Million11.48% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$7.56 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$5.35 Million0.61% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$4.96 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $91.9M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...